Jefferies Lifts Tenet Healthcare Target to $265, Citing Earnings, Cash Flow and Valuation Gap
Jefferies increased its price objective on Tenet Healthcare to $265 from $250 and kept a Buy rating, pointing to about 5% EBITDA growth, robust free cash flow, and an EV/EBITDA multiple below 8x. The move follows Tenet's better-than-expected fourth-quarter 2025 results and prompted a separate target increase from KeyBanc.